Axial SpA: Gender Gap Confirmed in TNF Inhibitor Response

(MedPage Today) -- Men with axial spondyloarthritis (axSpA) were more likely than women to obtain substantial relief with tumor necrosis factor (TNF) inhibitors, a multinational study indicated.
After 6 months of treatment with these agents, 66...

Source: MedPage Today Rheumatology - December 15, 2023 Category: Rheumatology Source Type: news